Antimicrobial therapy in the management of odontogenic infections: the penicillin-allergic patient
This retrospective analysis was performed to investigate whether clindamycin remains the preferred antibiotic for penicillin-allergic patients with odontogenic infections. The medical records of 311 patients admitted to the study department with odontogenic infections between 2018 and 2022 and treated with either intravenous amoxicillin –clavulanic acid (Augmentin) or intravenous clindamycin were analyzed. The Augmentin-treated group included 268 patients (86.2%) and the clindamycin-treated group included 43 patients (13.8%).
Source: International Journal of Oral and Maxillofacial Surgery - Category: ENT & OMF Authors: R. Mahmoud, S. Arbel, C. Ianculovici, O. Peleg, S. Kleinman, A. Shuster Tags: Clinical Paper Source Type: research
More News: Allergy & Immunology | Amoxicillin | Antibiotic Therapy | Augmentin | Clindamycin | ENT & OMF | Penicillin | Study